HLIO · Helios Technologies, Inc.

This option became exercisable in three equal annual installments beginning on January 28, 2022, which was the first anniversary of the date on which the option was granted.

The option became exercisable upon achievement of specified performance goals, beginning on the second anniversary of the grant date.

This option became exercisable in three equal annual installments beginning on February 28, 2021, which was the first anniversary of the date on which the option was granted.

The price shown is a weighted average sales price for shares sold in multiple transactions. The sales prices ranged from $89.88 to $90.69 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

The price shown is a weighted average sales price for shares sold in multiple transactions. The sales prices ranged from $89.67 to $90.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Each RSU represents the right to receive, following vesting, one share of Common Stock.

Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each anniversary of the grant date.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Upon vesting, there is no expiration.

The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.

The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.

Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029.

The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.